- Home
- NUVB vs EFSC Comparison
NUVB vs EFSC Comparison
Compare NUVB & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NUVB | EFSC |
|---|---|---|
| Founded | 2018 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | NUVB | EFSC |
|---|---|---|
| Price | $8.62 | $55.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | $9.63 | ★ $65.67 |
| AVG Volume (30 Days) | ★ 10.2M | 123.6K |
| Earning Date | 11-03-2025 | 10-27-2025 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | N/A | ★ 8.68 |
| EPS | N/A | ★ 5.13 |
| Revenue | $26,748,000.00 | ★ $646,694,000.00 |
| Revenue This Year | $283.17 | $20.14 |
| Revenue Next Year | $340.98 | $5.15 |
| P/E Ratio | ★ N/A | $10.80 |
| Revenue Growth | ★ 1137.19 | 9.31 |
| 52 Week Low | $1.54 | $45.22 |
| 52 Week High | $8.70 | $62.60 |
Technical Indicators
Market Signals| Indicator | NUVB | EFSC |
|---|---|---|
| Relative Strength Index (RSI) | 76.08 | 54.28 |
| Support Level | $7.46 | $54.04 |
| Resistance Level | $8.24 | $56.21 |
| Average True Range (ATR) | 0.62 | 1.31 |
| MACD | 0.13 | 0.33 |
| Stochastic Oscillator | 97.20 | 75.45 |
Price Performance
Historical ComparisonAbout NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.